Acid-triggered release of doxorubicin from a hydrazone-linked Gd3+-texaphyrin conjugate
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Min Hee | - |
dc.contributor.author | Kim, Eun-Joong | - |
dc.contributor.author | Lee, Hyunseung | - |
dc.contributor.author | Park, Sun Young | - |
dc.contributor.author | Hong, Kwan Soo | - |
dc.contributor.author | Kim, Jong Seung | - |
dc.contributor.author | Sessler, Jonathan L. | - |
dc.date.accessioned | 2021-09-04T05:12:21Z | - |
dc.date.available | 2021-09-04T05:12:21Z | - |
dc.date.created | 2021-06-18 | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1359-7345 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/90237 | - |
dc.description.abstract | The hydrazone-based Gd3+-texaphyrin doxorubicin conjugate 1, releases active doxorubicin at acidic pH values, allowing its components to be followed by two complementary imaging methods, namely Off-On fluorescence enhancement and MR imaging. It thus acts as a promising theranostic agent. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ROYAL SOC CHEMISTRY | - |
dc.subject | ANTICANCER DRUG-DELIVERY | - |
dc.subject | GADOLINIUM(III) TEXAPHYRIN | - |
dc.subject | MOTEXAFIN GADOLINIUM | - |
dc.subject | RADIATION SENSITIZER | - |
dc.subject | CANCER | - |
dc.subject | PRODRUG | - |
dc.subject | MECHANISMS | - |
dc.subject | EFFICACY | - |
dc.subject | REDUCTION | - |
dc.subject | THERAPY | - |
dc.title | Acid-triggered release of doxorubicin from a hydrazone-linked Gd3+-texaphyrin conjugate | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Jong Seung | - |
dc.identifier.doi | 10.1039/c6cc05673c | - |
dc.identifier.scopusid | 2-s2.0-84983656439 | - |
dc.identifier.wosid | 000382120300022 | - |
dc.identifier.bibliographicCitation | CHEMICAL COMMUNICATIONS, v.52, no.69, pp.10551 - 10554 | - |
dc.relation.isPartOf | CHEMICAL COMMUNICATIONS | - |
dc.citation.title | CHEMICAL COMMUNICATIONS | - |
dc.citation.volume | 52 | - |
dc.citation.number | 69 | - |
dc.citation.startPage | 10551 | - |
dc.citation.endPage | 10554 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Multidisciplinary | - |
dc.subject.keywordPlus | ANTICANCER DRUG-DELIVERY | - |
dc.subject.keywordPlus | GADOLINIUM(III) TEXAPHYRIN | - |
dc.subject.keywordPlus | MOTEXAFIN GADOLINIUM | - |
dc.subject.keywordPlus | RADIATION SENSITIZER | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | PRODRUG | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | REDUCTION | - |
dc.subject.keywordPlus | THERAPY | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.